The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer
Daisy B. Haigh(University of Nottingham), Nigel P. Mongan(University of Nottingham), Jenny L. Persson(Malmö University), Atara Ntekim(University College Hospital, Ibadan), Michael S. Toss(Nottingham City Hospital), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Emad A. Rakha(Nottingham University Hospitals NHS Trust), Catrin S. Rutland(University of Nottingham), Zsuzsanna Bódi(University of Nottingham), Veronika M. Metzler(University of Nottingham), Nathan Archer(University of Nottingham), Lorraine J. Gudas(Cornell University), Melissa B. Davis(Cornell University), Kristian B. Laursen, Francesca Khani(Cornell University), Jennifer Lothion‐Roy(University of Nottingham), Jennie N. Jeyapalan(University of Nottingham), Mansour Alsaleem(University of Nottingham), Anna E. Harris(University of Nottingham), Corinne L. Woodcock(University of Nottingham), Brian D. Robinson(Cornell University), Rupert G. Fray(University of Nottingham)
Cited by 32
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
|The Lancet Oncology|2013|605